Advanced search
Publication Cover
The American Journal of Drug and Alcohol Abuse
Encompassing All Addictive Disorders
Volume 13, 1987 - Issue 1-2
Submit an article Journal homepage
106
Views
95
CrossRef citations to date
0
Altmetric
Original Article

Clonidine and Naltrexone in the Outpatient Treatment of Heroin Withdrawal

Herbert D. Kleber Connecticut Mental Health Center New Haven, Connecticut, 06519
,
Mark Topazian Connecticut Mental Health Center New Haven, Connecticut, 06519
,
Joseph Gaspari Connecticut Mental Health Center New Haven, Connecticut, 06519
,
Charles E. Riordan Connecticut Mental Health Center New Haven, Connecticut, 06519
&
Thomas Kosten Connecticut Mental Health Center New Haven, Connecticut, 06519
Pages 1-17 | Published online: 07 Jul 2009

Citations (95)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (17)

Michael Soyka, Henry R. Kranzler, Wim van den Brink, John Krystal, Hans-Jürgen Möller & Siegfried Kasper. (2011) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence. The World Journal of Biological Psychiatry 12:3, pages 160-187.
Read now
Angela L Stotts, Carrie L Dodrill & Thomas R Kosten. (2009) Opioid dependence treatment: options in pharmacotherapy. Expert Opinion on Pharmacotherapy 10:11, pages 1727-1740.
Read now
Wilfrid Noel Raby, Kenneth M. Carpenter, Jami Rothenberg, Adam C. Brooks, Huiping Jiang, Maria Sullivan, Adam Bisaga, Sandra Comer & Edward V. Nunes. (2009) Intermittent Marijuana Use Is Associated with Improved Retention in Naltrexone Treatment for Opiate-Dependence. American Journal on Addictions 18:4, pages 301-308.
Read now
Tom Palmstierna. (2004) Effects of a High-Dose, Fast Tapering Buprenorphine Detoxification Program on Symptom Relief and Treatment Retention. Journal of Psychoactive Drugs 36:2, pages 273-277.
Read now
Gerardo Gonzalez, Alison Oliveto & Thomas R Kosten. (2004) Combating opiate dependence: a comparison among the available pharmacological options. Expert Opinion on Pharmacotherapy 5:4, pages 713-725.
Read now
Beth K Boyarsky & Elinore F. McCance-Katz. (2000) Improving the Quality of Substance Dependency Treatment with Pharmacotherapy. Substance Use & Misuse 35:12-14, pages 2095-2125.
Read now
DavidL. Simon. (1997) Rapid Opioid Detoxification Using Opioid Antagonists: History, Theory and the State of the Art. Journal of Addictive Diseases 16:1, pages 103-122.
Read now
Michael J. McCann, Karen Miotto, Richard A. Rawson, Alice Huber, Steven Shoptaw & Walter Ling. (1997) Outpatient Non-Opioid Detoxification for Opioid Withdrawal: Who Is Likely to Benefit?. American Journal on Addictions 6:3, pages 218-223.
Read now
John Merrill & Ruth Marshall. (1997) Opioid detoxification using naloxone. Drug and Alcohol Review 16:1, pages 3-6.
Read now
Thomas R. Kosten & Elinore McCance. (1996) A Review of Pharmacotherapies for Substance Abuse. American Journal on Addictions 5:sup1, pages S30-S37.
Read now
Thomas R. Kosten & Elinore McCance. (1996) A Review of Pharmacotherapie for Substance Abuse. American Journal on Addictions 5:1, pages 58-65.
Read now
Eric T. Moolchan & Jeffrey A. Hoffman. (1994) Phases of Treatment: A Practical Approach to Methadone Maintenance Treatment. International Journal of the Addictions 29:2, pages 135-160.
Read now
Michael S. Moncher, Gary W. Holden & Steven P. Schinke. (1991) Psychosocial Correlates of Adolescent Substance Use: A Review of Current Etiological Constructs. International Journal of the Addictions 26:4, pages 377-414.
Read now
Thomas R. Kosten, Charles Morgan & Herbert D. Kleber. (1991) Treatment of Heroin Addicts Using Buprenorphine. The American Journal of Drug and Alcohol Abuse 17:2, pages 119-128.
Read now
Warren A. Narducci, Jon C. Wagner, Todd P. Hendrickson & Timothy P. Jeffrey. (1990) Anabolic Steroids - a Review of the Clinical Toxicology and Diagnostic Screening. Journal of Toxicology: Clinical Toxicology 28:3, pages 287-310.
Read now
Yiannis Kasvikis, Brendan Bradley, Michael Gossop, Paul Griffiths & Isaac Marks. (1990) Clonidine Versus Long- and Short-Term Methadone-Aided Withdrawal from Opiates. An Uncontrolled Comparison. International Journal of the Addictions 25:10, pages 1169-1178.
Read now
Herbert D. Kleber. (1989) Treatment of Drug Dependence: What Works. International Review of Psychiatry 1:1-2, pages 81-99.
Read now

Articles from other publishers (78)

Adam Bisaga, Paolo Mannelli, Maria A. Sullivan, Suzanne K. Vosburg, Peggy Compton, George E. Woody & Thomas R. Kosten. (2018) Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies. The American Journal on Addictions 27:3, pages 177-187.
Crossref
Jana Katharina Wrosch, Vicky von Einem, Katharina Breininger, Marc Dahlmanns, Andreas Maier, Johannes Kornhuber & Teja Wolfgang Groemer. (2017) Rewiring of neuronal networks during synaptic silencing. Scientific Reports 7:1.
Crossref
Linda Gowing, Robert Ali & Jason M White. (2017) Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database of Systematic Reviews 2017:5.
Crossref
Brooke E Schmeichel, Estelle Barbier, Kaushik K Misra, Candice Contet, Joel E Schlosburg, Dimitri Grigoriadis, John P Williams, Camilla Karlsson, Caleb Pitcairn, Markus Heilig, George F Koob & Leandro F Vendruscolo. (2014) Hypocretin Receptor 2 Antagonism Dose-Dependently Reduces Escalated Heroin Self-Administration in Rats. Neuropsychopharmacology 40:5, pages 1123-1129.
Crossref
Clifford Gevirtz & Alan David Kaye. 2015. Pain Management and Palliative Care. Pain Management and Palliative Care 49 55 .
Carrie L. Wade, George F. Koob & Leandro F. Vendruscolo. 2014. Neurobiological Studies of Addiction in Chronic Pain States. Neurobiological Studies of Addiction in Chronic Pain States 61 79 .
Leandro F. Vendruscolo, Joel E. Schlosburg, Kaushik K. Misra, Scott A. Chen, Thomas N. Greenwell & George F. Koob. (2011) Escalation patterns of varying periods of heroin access. Pharmacology Biochemistry and Behavior 98:4, pages 570-574.
Crossref
Gerardo González & Mauricio Romero-González. (2010) Alternativas farmacológicas para el tratamiento de la dependencia a la heroína: un nuevo reto en Colombia. Revista Colombiana de Psiquiatría 39, pages 188S-212S.
Crossref
Linda Gowing, Robert Ali & Jason M White. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Paolo Mannelli, Ashwin A. Patkar, Kathi Peindl, David A. Gorelick, Li-Tzy Wu & Edward Gottheil. (2009) Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial. Addiction Biology 14:2, pages 204-213.
Crossref
Kevin A. Sevarino & Thomas R. Kosten. 2009. Opiate Receptors and Antagonists. Opiate Receptors and Antagonists 227 245 .
Enno Freye & Joseph Victor Levy. 2007. Opioids in Medicine. Opioids in Medicine 189 315 .
Enno Freye, Leo Latasch & Joseph Victor Levy. (2006) S(+)-Ketamine Attenuates Increase in Electroencephalograph Activity and Amplitude Height of Sensory-Evoked Potentials During Rapid Opioid Detoxification. Anesthesia & Analgesia 102:5, pages 1439-1444.
Crossref
Linda Gowing, Robert Ali & Jason M White. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Alan D. Kaye, Ron E. Banister, Jason M. Hoover, Amir R. Baluch, Scott Jacobs & Rinoo V. Shah. (2005) Chronic Pain and Ultrarapid Opioid Detoxification. Pain Practice 5:1, pages 33-42.
Crossref
E. Freye, L.B. Partecke & J.V. Levy. (2005) Increase in delta- and beta-wave activity of the EEG during rapid opiate detoxification (ROD)-reversal by administration of the non-specific NMDA-antagonist S(+) ketamine-. Neurophysiologie Clinique/Clinical Neurophysiology 35:1, pages 25-32.
Crossref
E Freye, J.V Levy & L Partecke. (2004) Use of gabapentin for attenuation of symptoms following rapid opiate detoxification (ROD). Neurophysiologie Clinique/Clinical Neurophysiology 34:2, pages 81-89.
Crossref
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 55 77 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 45 53 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 39 43 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 33 37 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 29 31 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 23 28 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 325 356 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 323 324 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 311 322 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 305 309 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 13 22 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 279 289 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 267 277 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 253 255 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 227 241 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 215 219 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 9 12 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 171 206 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 143 170 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 121 142 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 95 98 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 91 94 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 87 89 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 81 86 .
Enno FreyeEnno Freye. 2004. Opioide in der Medizin. Opioide in der Medizin 1 7 .
Herbert D. Kleber. (2003) Pharmacologic Treatments for Heroin and Cocaine Dependence. The American Journal on Addictions 12, pages S5-S18.
Crossref
Alan D. Kaye, Clifford Gevirtz, Hemmo A. Bosscher, Joe B. Duke, Elizabeth A. M. Frost, Todd A. Richards & Aaron M. Fields. (2003) Ultrarapid opiate detoxification: a reviewDésintoxication opiacée ultrarapide: une revue. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 50:7, pages 663-671.
Crossref
Gerardo Gonzalez, Alison Oliveto & Thomas R. Kosten. (2002) Treatment of Heroin (Diamorphine) Addiction. Drugs 62:9, pages 1331-1343.
Crossref
Gilberto Gerra, Amir Zaimovic, Francesca Giusti, Cristiana Di Gennaro, Ursula Zambelli, Simona Gardini & Roberto Delsignore. (2001) Lofexidine versus clonidine in rapid opiate detoxification. Journal of Substance Abuse Treatment 21:1, pages 11-17.
Crossref
Nina N Wong, Julie L Chen & Denise Luks-Golger. (2016) Absorption of Clonidine from a Halved Transdermal System — A Pilot Study. Journal of Pharmacy Technology 17:3, pages 84-89.
Crossref
J. Bearn, J. Bennett, T. Martin, M. Gossop & J. Strang. (2006) The impact of naloxone/lofexidine combination treatment on the opiate withdrawal syndrome. Addiction Biology 6:2, pages 147-156.
Crossref
Patrick G. O'ConnorDavid A. Fiellin. (2000) Pharmacologic Treatment of Heroin-Dependent Patients. Annals of Internal Medicine 133:1, pages 40.
Crossref
THAMIZAN K TUCKER & ALISON J. RITTER. (2009) Naltrexone in the treatment of heroin dependence: a literature review. Drug and Alcohol Review 19:1, pages 73-82.
Crossref
G. Gerra, A. Zaimovic, P. Rustichelli, B. Fontanesi, U. Zambelli, M. Timpano, C. Bocchi & R. Delsignore. (2000) Rapid opiate detoxication in outpatient treatment. Journal of Substance Abuse Treatment 18:2, pages 185-191.
Crossref
KEVIN A. SEVARINO, ALISON OLIVETO & THOMAS R. KOSTEN. (2006) Neurobiological Adaptations to Psychostimulants and Opiates as a Basis of Treatment Development. Annals of the New York Academy of Sciences 909:1, pages 51-87.
Crossref
Marc A. SchuckitMarc A. Schuckit. 2000. Drug and Alcohol Abuse. Drug and Alcohol Abuse 147 173 .
LYNETTE C. DAWS & JASON M. WHITE. (2006) Regulation of opioid receptors by opioid antagonists: implications for rapid opioid detoxification. Addiction Biology 4:4, pages 391-397.
Crossref
Shih-Ku Lin, John Strang, Lien-Wen Su, Chang-Jer Tsai & Wei-Herng Hu. (1997) Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal. Drug and Alcohol Dependence 48:2, pages 127-133.
Crossref
Patricia E Freed & Linda Nattkemper York. (1997) Naltrexone: A Controversial Therapy for Alcohol Dependence. Journal of Psychosocial Nursing and Mental Health Services 35:7, pages 24-28.
Crossref
Michael J. McCann, Karen Miotto, Richard A. Rawson, Alice Huber, Steven Shoptaw & Walter Ling. (2010) Outpatient Non‐Opioid Detoxification for Opioid Withdrawal. The American Journal on Addictions 6:3, pages 218-223.
Crossref
Barbara H. Herman & Charles P. O'Brien. (1997) Clinical Medications Development for Opiate Addiction: Focus on Nonopioids and Opioid Antagonists for the Amelioration of Opiate Withdrawal Symptoms and Relapse Prevention. Seminars in Neuroscience 9:3-4, pages 158-172.
Crossref
Thomas R. Kosten & Elinore McCance. (2010) A Review of Pharmacotherapies for Substance Abuse. The American Journal on Addictions 5:S1.
Crossref
Thomas R. Kosten & Elinore. McCance. (2010) A Review of Pharmacotherapies for Substance Abuse. The American Journal on Addictions 5:1, pages 58-65.
Crossref
Michael Farrell & John Strang. (2016) Compressed opiate withdrawal syndrome and naltrexone. Journal of Psychopharmacology 9:4, pages 383-385.
Crossref
Patrick G. O’Connor, Martin E. Waugh, Kathleen M. Carroll, Bruce J. Rounsaville, Ioannis A. Diagkogiannis & Richard S. Schottenfeld. (2018) Primary care-based ambulatory opioid detoxification. Journal of General Internal Medicine 10:5, pages 255-260.
Crossref
Gilberto Gerra, Antonio Marcato, Rocco Caccavari, Bruno Fontanesi, Roberto Delsignore, Giuseppe Fertonani, Paola Avanzini, Paolo Rustichelli & Mario Passeri. (1995) Clonidine and opiate receptor antagonists in the treatment of heroin addiction. Journal of Substance Abuse Treatment 12:1, pages 35-41.
Crossref
Patrick G. O’Connor, Martin E. Waugh, Richard S. Schottenfeld, Ioannis A. Diakogiannis & Bruce J. Rounsaville. (1992) Ambulatory opiate detoxification and primary care. Journal of General Internal Medicine 7:5, pages 532-534.
Crossref
Peter A. Selwyn & Patrick G. O'Connor. (1992) DIAGNOSIS AND TREATMENT OF SUBSTANCE USERS WITH HIV INFECTION. Primary Care: Clinics in Office Practice 19:1, pages 119-156.
Crossref
Pierre Lauzon. (1992) Two cases of clonidine abuse/dependence in methadone-maintained patients. Journal of Substance Abuse Treatment 9:2, pages 125-127.
Crossref
Robert A. Senft. (1991) Experience with clonidine-naltrexone for rapid opiate detoxification. Journal of Substance Abuse Treatment 8:4, pages 257-259.
Crossref
Judith R. Morgan. 1990. Substance Abuse and Dependence. Substance Abuse and Dependence 98 130 .
Colin Brewer & K.I. Mathew. (1989) NALOXONE AND OPIATE ADDICTION. The Lancet 334:8664, pages 683-684.
Crossref
D. Colin Drummond & Douglas Turkington. (2018) Naltrexone and Clonidine in Heroin Withdrawal Treatment. British Journal of Psychiatry 154:4, pages 571-572.
Crossref
Colin Brewer. (2018) [No Title]. British Journal of Psychiatry 154:4, pages 572-572.
Crossref
Colin Brewer, Hussein Rezae & Clayton Bailey. (2018) Opioid Withdrawal and Naltrexone Induction in 48–72 Hours with Minimal Drop-out, Using a Modification of the Naltrexone-Clonidine Technique. British Journal of Psychiatry 153:3, pages 340-343.
Crossref
Colin Brewer. (2018) Naloxone in Heroin Withdrawal. British Journal of Psychiatry 153:1, pages 120-120.
Crossref
M. Gossop. (1988) Clonidine and the treatment of the opiate withdrawal syndrome. Drug and Alcohol Dependence 21:3, pages 253-259.
Crossref
C. Brewer. (1988) Drug addicts and the GP. BMJ 296:6634, pages 1470-1471.
Crossref
EUGENIA VINING, THOMAS R. KOSTEN & HERBERT D. KLEBER. (2010) Clinical Utility of Rapid Clonidine‐naltrcxone Detoxification for Opioid Abusers. British Journal of Addiction 83:5, pages 567-575.
Crossref
Thomas R. Kosten & Herbert D. Kleber. (1988) Buprenorphine detoxification from opiod dependence: A pilot study. Life Sciences 42:6, pages 635-641.
Crossref
Thomas R. Kosten & John Krystal. 1988. Recent Developments in Alcoholism. Recent Developments in Alcoholism 49 68 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.